Ebola vaccine promising in first human trials: National Institutes of Health

An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.



from Zee News :World http://ift.tt/1z03bYl

via IFTTT